Key statistics
As of last trade, NuCana PLC (N04:MUN) traded at 1.95, 10.17% above the 52 week low of 1.77 set on Oct 08, 2024.
52-week range
Open | 1.95 |
---|---|
High | 1.95 |
Low | 1.95 |
Bid | 2.00 |
Offer | 2.06 |
Previous close | 1.93 |
Average volume | 544.44 |
---|---|
Shares outstanding | 90.66k |
Free float | 67.99k |
P/E (TTM) | -- |
Market cap | 4.92m USD |
EPS (TTM) | -230.37 USD |
Data delayed at least 15 minutes, as of Oct 10 2024 07:01 BST.
More ▼
Announcements
- NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
- NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
- NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study
- NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
- NuCana to Present at the Jefferies Global Healthcare Conference
- NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
- NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
- NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
- NuCana Announces Completion of ADS Ratio Change
- NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
More ▼